CML
News
CML patients die from comorbidities, not leukemia
Key clinical point: Patients with chronic myeloid leukemia treated with imatinib are much more likely to die from comorbid conditions than from...
News
Radiation increases risk of death from CML, other leukemias
power plant in Germany Protracted exposure to ionizing radiation, even at low doses, can increase a person’s risk of dying from certain leukemias...
Conference Coverage
Nivolumab produces ‘dramatic’ responses in HL
Photo courtesy of UCLA LUGANO—The PD-1 checkpoint inhibitor nivolumab produces rapid, durable, and, in some cases, “dramatic” responses in...
Conference Coverage
Dose reductions make ponatinib safer for CP-CML
VIENNA—Administering ponatinib at lower doses can reduce the risk of arterial occlusive events (AOE) without hindering responses in patients with...
Conference Coverage
EHA: Dasatinib gets early edge over imatinib in CML
Key clinical point: Dasatinib provides more molecular responses than imatinib, but no survival advantage at 2 years in the first-line treatment of...
Conference Coverage
MKIs can overcome resistance in CML
PHILADELPHIA—Two multikinase inhibitors (MKIs) can treat chronic myeloid leukemia (CML) that is resistant to other inhibitors, according to...
News
Drug approved to treat CML, ALL in Canada
Photo courtesy of the FDA Health Canada has approved ponatinib hydrochloride (Iclusig) to treat adults with any phase of chronic myeloid leukemia...
News
Study reveals potential strategy for treating CML
Image courtesy of UCSD New discoveries concerning a well-known tumor suppressor protein could help advance the diagnosis and treatment of chronic...
News
Israel approves ponatinib for CML, Ph+ ALL
Photo courtesy of the US FDA The Israeli Ministry of Health has granted regulatory approval for the kinase inhibitor ponatinib (Iclusig) to treat...
News
Skiing accident claims life of leukemia expert
Photo courtesy of RPCI Meir Wetzler, MD, Chief of the Leukemia Section at the Roswell Park Cancer Institute (RPCI) in Buffalo, New York, has died...
News
Evolutionary findings may aid cancer drug development
Photo by Darren Baker By tracking the evolution of Abl and Src, investigators have made discoveries that may aid the design of highly specific...